or Try an Advanced Search...

    Technical Analysis for GOSS - Gossamer Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.74 1.28% 0.01
    GOSS closed up 1.28 percent on Wednesday, May 15, 2024, on 1.14 times normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical GOSS trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    20 DMA Resistance Bearish 1.28%
    Bollinger Band Squeeze Range Contraction 1.28%
    BB Squeeze Started Range Contraction 1.28%
    Outside Day Range Expansion 1.28%
    20 DMA Resistance Bearish 3.08%
    Narrow Range Bar Range Contraction 3.08%
    Down 3 Days in a Row Weakness 3.08%
    20 DMA Resistance Bearish -0.01%
    Older End-of-Day Signals for GOSS ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 20 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    Rose Above Previous Day's High about 20 hours ago
    Rose Above 10 DMA about 20 hours ago
    Up 3% about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GOSS Chart by TradingView
    Basic chart:

    Profile

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Life Sciences Disease Immunology Inflammation Millennium Pharmaceuticals

    Is GOSS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
    May 7 Gossamer Bio GAAP EPS of -$0.19 in-line
    May 7 Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
    May 7 Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
    May 6 Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
    May 6 UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
    May 6 Gossamer sells rights to drug it hopes can rival a new Merck therapy
    May 6 Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
    May 3 Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
    Apr 26 Gossamer Bio Decline Means Insider Profits Down To US$17k
    See more GOSS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.88
    52 Week Low 0.4525
    Average Volume 1,749,758
    200-Day Moving Average 0.93
    50-Day Moving Average 1.02
    20-Day Moving Average 0.73
    10-Day Moving Average 0.75
    Average True Range 0.07
    RSI (14) 39.76
    ADX 31.51
    +DI 10.91
    -DI 16.02
    Chandelier Exit (Long, 3 ATRs) 0.65
    Chandelier Exit (Short, 3 ATRs) 0.85
    Upper Bollinger Bands 0.80
    Lower Bollinger Band 0.67
    Percent B (%b) 0.55
    BandWidth 18.89
    MACD Line -0.06
    MACD Signal Line -0.08
    MACD Histogram 0.0183
    Fundamentals Value
    Market Cap 167.3 Million
    Num Shares 225 Million
    EPS -1.60
    Price-to-Earnings (P/E) Ratio -0.46
    Price-to-Sales 0.00
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.81
    Resistance 3 (R3) 0.81 0.79 0.80
    Resistance 2 (R2) 0.79 0.77 0.79 0.80
    Resistance 1 (R1) 0.76 0.76 0.75 0.77 0.79
    Pivot Point 0.74 0.74 0.73 0.74 0.74
    Support 1 (S1) 0.72 0.72 0.71 0.72 0.69
    Support 2 (S2) 0.69 0.71 0.69 0.69
    Support 3 (S3) 0.67 0.69 0.68
    Support 4 (S4) 0.67